ClinicalTrials.Veeva

Menu

Children and Parents With ADHD and Related Disorders (ChiP-ARD)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Children Aged 5 to 18 Years
TDAH
General Population

Treatments

Other: Questionnaire
Other: questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT01260792
09-APN-02

Details and patient eligibility

About

Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also research in this domain. This study is conceived to collect data in the general population of children aged from 4 to 18 years in public schools in the city of Nice.

Children are pseudo-randomly selected from classes of randomly selected schools in the city of Nice (France). Teachers fill out questionnaires using a dedicated secured website, and ask parents to fill out a similar set of questionnaires regarding their child's behaviour at home. Since ADHD has a strong genetic components, parents are also asked to fill out questionnaires regarding their own behaviour at adulthood and in childhood retrospectively.

Additionally, known factors related to ADHD and other disorders as well as other putative factors are tested in the epidemiologic study.

Enrollment

2,600 patients

Sex

All

Ages

5 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Child known for the teacher for at least three months so that his evaluation Reflect most faithfully possible the usual behavior of the child,
  • Child having the Frenchman for mother tongue to avoid the consequences on him Behavior of a linguistic obstacle,
  • Authorization to use the data signed by at least one of the parents of the child and by the very child when he is old at least of six years.
  • Parents speaking and reading the Frenchman.

Exclusion criteria

  • Child known to follow a specific treatment of a disorder(confusion)attentional with / without Hyperactivity-impulsiveness (eg. Ritaline Ò, Ritaline Ò LP, Arranged Ò LP, Strattera Ò) Whatever is its duration. Indeed, a selection on this criterion would introduce a way Major which(who) would return the less reliable results(profits) of the study.
  • Child presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\or psychiatric.

Trial design

2,600 participants in 2 patient groups

Children
Description:
Children between 5 and 18 years old.
Treatment:
Other: questionnaire
Adults
Description:
Parents of children between 5 and 18 years old
Treatment:
Other: Questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems